Filing Details
- Accession Number:
- 0001140361-13-004305
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-04 10:05:36
- Reporting Period:
- 2013-01-31
- Filing Date:
- 2013-02-04
- Accepted Time:
- 2013-02-04 10:05:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1350577 | Ali Naqui | One Idexx Drive Westbrook ME 04092 | Corporate Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-01-31 | 11,498 | $41.94 | 23,418 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-01-31 | 8,540 | $95.53 | 14,878 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-01-31 | 8,540 | $0.00 | 8,540 | $41.94 |
Common Stock | Incentive Stock Option (right to buy) | Disposition | 2013-01-31 | 2,958 | $0.00 | 2,958 | $41.94 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-02-13 | No | 4 | M | Direct | |
0 | 2014-02-13 | No | 4 | M | Direct |
Footnotes
- Grant of options to buy shares of common stock becomes exercisable as to 2,300 shares on 02/14/2008, 02/14/2009 and 02/14/2010 and the remaining 1,640 shares on 02/14/2011.
- Grant of options to buy shares of common stock becomes exercisable as to 660 shares on 02/14/2011 and the remaining 2,298 shares on 02/14/2012.